Asia-Pacific Biotech News

The article summarises Asia as a biotechnology hub focusing on Singapore, Taiwan, Malaysia, India, Japan, China, Hong Kong, South Korea, Sri Lanka and Thailand. It describes how Asia is one of the more attractive locations for global biotechnology companies to invest in highly skilled staff and world class technologies.

The article discusses the major biotech products and services that China is providing. It touches on the characteristics and trends of the Chinese biotechnology market. It also introduces ways of marketing potential products and services.

The article discusses on what the Hong Kong government are doing to boost biomedical investments. It touches briefly on the biotechnology market and Hong Kong government policy for Innovation and Technology. It also includes some examples of biotech companies.

The article written by a very experienced veteran in the biotechnology sector, Dr Mazumdar Shaw describes India's biopharma sector and also shows a sectoral roadmap. It touches on agriculture and food biotechnology, industrial biotechnology, diagnostic biotechnology, regenerative medicine, therapeutic biotechnology, pharmaocogenomics, nanotechnology and bioinformatics.

The article discusses the Japanese Biotechnology market which lists human health, agri-food, bioprocess, environment, biotools and bioinformatics as the main industries. It shows a map of structural reorganization in Japan. It also discusses the areas of improvement of the Japanese market.

The article discusses about the National Biotechnology policy and the biotechnology industry in Malaysia. It talks about the incentives and grants that the Malaysian government has for their investors and researchers. It also states the factors why investors should consider Malaysia as a country they can invest in.

The article touches on the trend of the biotechnology market in Singapore. It discusses about the growing base of drug discovery and development activities. It also states the new bio-enterprises and the world class scientists that Singapore has attracted.

The article is about the research portfolio of South Korea. It also touches on South Korea's competitive edge over other Asia countries. It includes a table on the South Korean Bioindustry Sectors.

The article touches on the key stakeholders of the biotech companiesin Taiwan. It also discusses the regulatory bodies and the government funding and taxation, strengths and opportunties and Taiwan's potential.